Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 1.30B | 1.98B | |
| Total Depreciation and Amortization | -- | -- | 199.69M | 202.46M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -1.69B | -1.44B | |
| Change in Net Operating Assets | -- | -- | 3.28B | 1.98B | |
| Cash from Operations | -- | -- | 3.10B | 2.72B | |
| Capital Expenditure | -- | -- | -447.37M | -393.13M | |
| Sale of Property, Plant, and Equipment | -- | -- | 47.59M | -4.11M | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -856.50M | -1.44B | |
| Cash from Investing | -- | -- | -1.26B | -1.84B | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | 4.01B | 1.98B | |
| Issuance of Common Stock | -- | -- | 200.00M | 208.00M | |
| Repurchase of Common Stock | -- | -- | -7.00M | -8.00M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -1.07B | -1.07B | |
| Other Financing Activities | -- | -- | -11.99B | -10.00B | |
| Cash from Financing | -- | -- | -1.12B | -1.12B | |
| Foreign Exchange rate Adjustments | -- | -- | -9.53M | -10.03M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | 6.90K | -5.90K | |
| Net Change in Cash | -- | -- | 705.74M | -247.66M | |